CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $262.91M, lower than 95% of all stocks globally
- PositionCurrent ratio is 14.94×, higher than 95% of its Diagnostics & Research peers (median 2.49×)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
2.28%
Annual Rate
CNY 1.00Paid annual
Payout Ratio
244.7%High
Payback Period
41.3 yr
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.75BCNY262.91M · vs all stocks (USD)
Trailing P/E
93.15xvs Diagnostics & Research peers
Revenue (TTM)
160.14MCNY24.00M · vs all stocks (USD)
Profit Margin
11.01%vs Diagnostics & Research peers
Beta
0.3550xvs all stocks
52-Week Change
-11.61%vs all stocks
Market Capitalization
1.75BCNY262.91M · vs all stocks (USD)
Enterprise Value
902.47MCNY135.25M · vs all stocks (USD)
Trailing P/E
93.15xvs Diagnostics & Research peers
Price to Sales (TTM)
10.95xvs Diagnostics & Research peers
Price to Book (MRQ)
1.92xvs Diagnostics & Research peers
Enterprise to Revenue
5.64xvs Diagnostics & Research peers
Enterprise to EBITDA
60.25xvs Diagnostics & Research peers
Gross Margin
81.74%vs Diagnostics & Research peers
Profit Margin
11.01%vs Diagnostics & Research peers
Operating Margin
-5.03%vs Diagnostics & Research peers
Return on Assets (TTM)
0.13%vs Diagnostics & Research peers
Return on Equity (TTM)
1.96%vs Diagnostics & Research peers
Revenue (TTM)
160.14MCNY24.00M · vs all stocks (USD)
Revenue per Share (TTM)
4.05CNYUpdated Oct 24, 2026Quarterly Revenue Growth
-7.90%vs Diagnostics & Research peers
Gross Profit (TTM)
123.76MCNY18.55M · vs all stocks (USD)
EBITDA (TTM)
13.50MCNY2.02M · vs all stocks (USD)
Net Income (TTM)
17.62MCNY2.64M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
460.60%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
21.39MCNY3.21M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
11.66MCNY1.75M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.00CNYUpdated Oct 24, 2026Trailing Annual Dividend Yield
2.28%vs all stocks
Payout Ratio
244.68%vs Diagnostics & Research peers
Revenue
161.94MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
35.56MCNYFY2025 · Dec 31, 2025Gross Profit
126.38MCNYFY2025 · Dec 31, 2025Operating Income
-14.27MCNY-2.14M · vs all stocks (USD)
Pre-tax Income
10.22MCNYFY2025 · Dec 31, 2025Income Tax Expense
131.66KCNYFY2025 · Dec 31, 2025Net Income
10.09MCNYFY2025 · Dec 31, 2025EBIT
10.46MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
13.50MCNYFY2025 · Dec 31, 2025Research & Development
34.59MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
50.44MCNYFY2025 · Dec 31, 2025Other Operating Expenses
2.10MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.60MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
236.40KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
38.80MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
38.80MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
10.09MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
37.16MCNYFY2025 · Dec 31, 2025Free Cash Flow
30.29MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
97.43MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
10.09MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.22MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
19.80MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
4.05MCNYFY2025 · Dec 31, 2025Capital Expenditures
-6.86MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.24BCNYFY2025 · Dec 31, 2025Sale of Investments
2.07BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-175.80MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-9.69MCNYFY2025 · Dec 31, 2025Other Financing Charges
147.27KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-9.54MCNYFY2025 · Dec 31, 2025Shares Outstanding
40.07MSharesUpdated Oct 24, 2026Float Shares
18.18MSharesUpdated Oct 24, 2026% Held by Insiders
51.67%vs all stocks
% Held by Institutions
4.30%vs all stocks
Total Cash (MRQ)
784.82MCNY117.62M · vs all stocks (USD)
Total Cash per Share (MRQ)
20.24CNYUpdated Oct 24, 2026Total Debt (MRQ)
4.69MCNY703.44K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0053xvs Diagnostics & Research peers
Current Ratio (MRQ)
14.94xvs Diagnostics & Research peers
Book Value per Share (MRQ)
22.80CNYUpdated Oct 24, 2026Total Assets
990.17MCNY148.40M · vs all stocks (USD)
Total Current Assets
890.66MCNYFY2025 · Dec 31, 2025Total Liabilities
76.26MCNYFY2025 · Dec 31, 2025Total Non-current Assets
99.51MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
7.29MCNYFY2025 · Dec 31, 2025Total Current Liabilities
68.97MCNYFY2025 · Dec 31, 2025Cash
97.37MCNYFY2025 · Dec 31, 2025Cash Equivalents
60.93KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
97.44MCNYFY2025 · Dec 31, 2025Other Short-term Investments
693.47MCNYFY2025 · Dec 31, 2025Accounts Receivable
44.79MCNYFY2025 · Dec 31, 2025Inventory
21.24MCNYFY2025 · Dec 31, 2025Accounts Payable
2.70MCNYFY2025 · Dec 31, 2025Short-term Debt
2.70MCNYFY2025 · Dec 31, 2025Other Current Liabilities
313.85KCNYFY2025 · Dec 31, 2025Long-term Debt
3.36MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
34.25KCNYFY2025 · Dec 31, 2025Common Stock (Book)
40.07MCNYFY2025 · Dec 31, 2025Retained Earnings
114.37MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
913.91MCNY136.97M · vs all stocks (USD)
Treasury Stock
35.66MCNYFY2025 · Dec 31, 202552-Week Low
40.00CNYUpdated Oct 24, 202652-Week High
63.56CNYUpdated Oct 24, 202652-Week Change
-11.61%vs all stocks
Beta
0.3550xvs all stocks
50-Day MA
48.14CNYUpdated Oct 24, 2026200-Day MA
50.96CNYUpdated Oct 24, 2026Avg 10-Day Volume
658.39KSharesUpdated Oct 24, 2026Avg 30-Day Volume
545.06KSharesUpdated Oct 24, 2026Diluted EPS (TTM)
0.4700CNYUpdated Oct 24, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 14.94×, higher than 95% of its Diagnostics & Research peers (median 2.49×)Significant
Current ratio: 14.94Industry median: 2.49Industry P95: 10.30Peers compared: 30.00
Debt-to-equity is 0.01×, lower than 95% of its Diagnostics & Research peers (median 0.16×)Notable
Debt-to-equity: 0.01Industry median: 0.16Industry P5: 0.01Peers compared: 30.00
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 2.45Dividend per Share: 1.00Earnings per Share: 0.47
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $262.91M, lower than 95% of all stocks globallySignificant
Market cap (USD): 262,910,782.542Global P5: 267,399,448.3
Revenue is $24M, lower than 95% of all stocks globallySignificant
Revenue (USD): 23,999,814.918Global P5: 36,021,613.518
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhangjiagang Haiguo New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Zhongtian Service Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Hangzhou iEcho Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sukegawa Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
GK Energy Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Formosan Rubber Group Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shenzhen Textile Holdings Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shiyan Taixiang Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Touchstone International Holdings Limited
Tier 1ProductionThroughput-Bound ConversionRule
Jiangsu Smartwin Electronics Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Great Eastern Shipping Company Ltd.
3 interpretationsLow-Leverage Liquidity ConfigurationCash-Flow Ratios ElevatedMinimal Tax and Interest Drag
Zhubo Design Co. Ltd.
3 interpretationsLow-Leverage Liquidity ConfigurationCash-Flow Ratios ElevatedMinimal Tax and Interest Drag
ULG
3 interpretationsLow-Leverage Liquidity ConfigurationCash-Flow Ratios ElevatedMinimal Tax and Interest Drag